OSRH

OSR Holdings, Inc. OSRH

OSRH
OSR Holdings, Inc. EVGN
Evogene Ltd. DWTX
Dogwood Therapeutics, Inc. ACXP
Acurx Pharmaceuticals, Inc. ABP
Abpro Corporation BOLT
Bolt Biotherapeutics, Inc. MRKR
Marker Therapeutics, Inc. LYRA
Lyra Therapeutics, Inc. BRTX
BioRestorative Therapies, Inc. COCP
Cocrystal Pharma, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode OSRH EVGN DWTX ACXP ABP BOLT MRKR LYRA BRTX COCP
6M -56.26 % 12.61 % 6.33 % -19.53 % -37.11 % -23.08 % -17.60 % 20.19 % -8.19 % -30.99 %
YTD -94.68 % -35.57 % 134.26 % -61.25 % -87.26 % -47.37 % -67.61 % -41.57 % 5.37 % -49.14 %
1Y -94.68 % -47.48 % 20.74 % -82.78 % -96.53 % -55.82 % -76.16 % -50.20 % -0.63 % -36.22 %
3Y -94.68 % -84.61 % -18.90 % -89.43 % -96.53 % -77.78 % -77.12 % -97.39 % -53.82 % -45.62 %
5Y -94.68 % -95.73 % -98.59 % -95.87 % -96.53 % -99.07 % -93.52 % -98.96 % -98.68 % -88.70 %
10Y -94.68 % -98.44 % -98.59 % -95.87 % -96.53 % -99.07 % -98.44 % -99.32 % -99.99 % -99.57 %
Depuis le début -94.68 % -90.74 % -98.59 % -95.87 % -96.53 % -99.07 % -100.00 % -99.32 % -100.00 % -99.87 %

Dividende

Bolt Biotherapeutics, Inc.